D. Keith Grossman

MiniMed is a full-stack insulin delivery company built around one belief: that technology should lift the burden of diabetes. So that every day is a better day. Days when diabetes fades into the background and life takes the lead. Joyful, messy, fully lived days — when things feel lighter, easier, more possible. Those are the days we’re here to make real. Connect with us! Facebook @ www.facebook.com/MiniMed Instagram @ www.instagram.com/minimed/ X @ https://x.com/minimed TikTok @ https://www.tiktok.com/@minimed YouTube @ https://www.youtube.com/@MiniMed_US

Supira Medical, a clinical-stage Shifamed portfolio company, is focused on development of a next-generation pVAD for use in high-risk patients undergoing interventional procedures and experiencing cardiogenic shock. To learn more about Supira Medical, please visit www.supiramedical.com.

Bank of America founder A.P. Giannini was committed to promoting the treatment of human disease. On his 75th birthday, May 6, 1945, he created and endowed the A.P. Giannini Foundation to support innovative research in the basic sciences and applied fields. Since its inception, the Foundation has provided funding to over 1,000 postdoctoral biomedical researchers at California’s accredited medical schools. Giannini postdoctoral fellows are among the most highly respected medical and scientific investigators in their fields and have served as mentors to succeeding generations of young scientists. http://www.apgianninifoundation.org

Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem is the #1 recommended insulin pump brand by people living with diabetes, four years and counting. (dQ&A US Diabetes Connections Patient Panel Report; Net Promoter Score; Q1 2019-Q3 2023: P.49, Q3 2023 (Jan. 2019-Sept. 2023). Tandem Diabetes Care is based in San Diego, California. For more information, visit tandemdiabetes.com. SAFETY INFORMATION Please note that this account is not intended to be used for product support or medical advice. If you are having a medical emergency, please dial 911. If you are having an issue with one of our products and need immediate assistance, please call our 24-hour customer support team at 877-801-6901 and press 1 twice. RX ONLY. Indicated for patients with type 1 diabetes, 6 years and older. WARNING: Control-IQ technology should not be used by people under age 6, or who use less than 10 units of insulin/day, or who weigh less than 55 lbs. Safety info: tandemdiabetes.com/safetyinfo.

Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, Calif., is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. At Intuitive, we believe that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints.

MiniMed is a full-stack insulin delivery company built around one belief: that technology should lift the burden of diabetes. So that every day is a better day. Days when diabetes fades into the background and life takes the lead. Joyful, messy, fully lived days — when things feel lighter, easier, more possible. Those are the days we’re here to make real. Connect with us! Facebook @ www.facebook.com/MiniMed Instagram @ www.instagram.com/minimed/ X @ https://x.com/minimed TikTok @ https://www.tiktok.com/@minimed YouTube @ https://www.youtube.com/@MiniMed_US

Supira Medical, a clinical-stage Shifamed portfolio company, is focused on development of a next-generation pVAD for use in high-risk patients undergoing interventional procedures and experiencing cardiogenic shock. To learn more about Supira Medical, please visit www.supiramedical.com.

Bank of America founder A.P. Giannini was committed to promoting the treatment of human disease. On his 75th birthday, May 6, 1945, he created and endowed the A.P. Giannini Foundation to support innovative research in the basic sciences and applied fields. Since its inception, the Foundation has provided funding to over 1,000 postdoctoral biomedical researchers at California’s accredited medical schools. Giannini postdoctoral fellows are among the most highly respected medical and scientific investigators in their fields and have served as mentors to succeeding generations of young scientists. http://www.apgianninifoundation.org

At ViewRay, our vision is clear: conquer cancer by re-envisioning radiation therapy., giving doctors new and better ways to treat their patients. ViewRay®, Inc. (NASDAQ:VRAY) shifts the paradigm in cancer treatment with the MRIdian® MRI-guided adaptive radiotherapy system. We’re changing radiation therapy for the better with accurate, precise and personalized cancer treatment that no other system delivers, addressing the key limitations of existing external-beam radiation therapy technologies. Real-time imaging clearly defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment. MRIdian shapes the dose to fit the day. It’s the only MR solution that enables fully integrated adaptive treatment with complete, on-table re-optimization of the daily treatment plan. It knows when to strike – and when to stop. MRIdian is the only RT solution with automated beam gating for precise and accurate dosing. When the tumor moves, the beam stops. The result? Better outcomes for patients. After seven years of clinical use, MRIdian has treated more than 12,500 patients worldwide. We’re an innovative, entrepreneurial company with big ambitions, unlimited potential and a passion for a culture that is diverse and committed to our physicians and their patients. If you’re ready to change the way the world views cancer, come join our team.

MDMA is a national trade association that provides educational and advocacy services to medical technology innovators. For over 25 years, MDMA has served as the eyes and ears for the medical device industry in Washington, DC and beyond. We provide advocacy services on behalf of the industry that promote patient access and innovation. We offer professional development services to member company personnel including conferences and a variety of other educational resources. Our mission is to ensure patients have timely access to safe and effective medical products that improve health outcomes. MDMAs membership is broad and diverse, ranging from the small innovators working to develop the next generation of life saving products to the largest medical device companies in the world. We also provide services to other industry stakeholders including medical technology investors and consultants ranging from legal service providers, regulatory, reimbursement and other subject matter experts.